Loading patent…
AssigneeInnovac Corporation
InventorsTae Wook HAHN, Ki Ju KIM, Kyu Sung CHOI
Estimating the term…
The present invention relates to a novel recombinant porcine circovirus type 2 protein and use thereof and, more specifically, to: a novel recombinant porcine circovirus type 2 protein; and a vaccine composition, an immunogenic composition, and a feed composition, comprising same. It was confirmed that the novel recombinant porcine circovirus type 2 protein according to the present invention showed excellent antibody titers against both PCV2b and type 2d. This means that when the recombinant porcine circovirus type 2 protein of the present invention is used as a vaccine, porcine circovirus-related diseases can be effectively prevented by cross-protecting both PCV2b and PCV2d genotypes, and thus the porcine circovirus type 2 protein of the present invention can be used in various ways in the field of pig farming.
-11. (canceled)
A nucleic acid encoding a recombinant porcine circovirus type 2 (PCV2) protein represented by a nucleotide sequence represented by SEQ ID NO:
A recombinant porcine circovirus type 2 protein encoded by a nucleotide sequence represented by SEQ ID NO:
A method for preventing, improving, or treating infectious diseases of porcine circovirus type 2, the method comprising step of administering a composition comprising a recombinant porcine circovirus type 2 protein encoded by a nucleotide sequence represented by SEQ ID NO:
Dependencies are inferred from the claim text.